In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
Novartis completes agreement with Bayer Schering related to Betaseron® rights and manufacturing
Bayer Schering Pharma strengthens its oncology R&D portfolio
SciGen & Bioton sign agreement with Bayer Schering Pharma in China
Bayer Intensifies Research in Early Diagnosis of Alzheimer’s Disease
Exclusive licensing option for solid tumor antibody
Exclusive licensing option for solid tumor antibody
Phenex AG provides compound profiling services to Bayer- Schering Pharma AG